Sabarinath Venniyil Radhakrishnan, Neelam Bhardwaj, Mary Steinbach, Janet Weidner, Tim Luetkens, & Djordje Atanackovic. (2017). Elotuzumab as a novel anti-myeloma immunotherapy. Taylor & Francis Group.
Chicago Style (17th ed.) CitationSabarinath Venniyil Radhakrishnan, Neelam Bhardwaj, Mary Steinbach, Janet Weidner, Tim Luetkens, and Djordje Atanackovic. Elotuzumab as a Novel Anti-myeloma Immunotherapy. Taylor & Francis Group, 2017.
MLA (9th ed.) CitationSabarinath Venniyil Radhakrishnan, et al. Elotuzumab as a Novel Anti-myeloma Immunotherapy. Taylor & Francis Group, 2017.
Warning: These citations may not always be 100% accurate.